Matches in SemOpenAlex for { <https://semopenalex.org/work/W2136318351> ?p ?o ?g. }
- W2136318351 endingPage "2364" @default.
- W2136318351 startingPage "2360" @default.
- W2136318351 abstract "The growing number of infections caused by multidrug-resistant pathogens has prompted a more rational use of available antibiotics given the paucity of new, effective agents. Monte Carlo simulations were utilized to determine the appropriateness of several doripenem dosing regimens based on the probability of attaining the critical drug exposure metric of time that drug concentrations remain above the drug MIC (T>MIC) for 35% (and lower thresholds) of the dosing interval in >80 to 90% of the population (T>MIC 35% target). This exposure level generally correlates with in vivo efficacy for carbapenems. In patients with creatinine clearance of >50 ml/min, a 500-mg dose of doripenem infused over 1 h every 8 h is expected to be effective against bacilli with doripenem MICs of < or =1 microg/ml based on a T>MIC 35% target and MICs of < or =2 microg/ml based on lower targets. A longer, 4-hour infusion time improved target attainment in most cases, such that the T>MIC was adequate for pathogens with doripenem MICs as high as 4 microg/ml. Efficacy is expected for infections caused by pathogens with doripenem MICs of < or =2 microg/ml in patients with moderate renal impairment (creatinine clearance, 30 to 50 ml/min) who receive doripenem at 250 mg infused over 1 h every 8 h and in patients with severe impairment (creatinine clearance between 10 and 29 ml/min) who receive doripenem at 250 mg, infused over 1 h or 4 h, every 12 h. Results of pharmacokinetics/pharmacodynamics (PK/PD) modeling can guide dose optimization, thereby potentially increasing the clinical efficacy of doripenem against serious Gram-negative bacterial infections." @default.
- W2136318351 created "2016-06-24" @default.
- W2136318351 creator A5006715126 @default.
- W2136318351 creator A5023581417 @default.
- W2136318351 creator A5075045252 @default.
- W2136318351 creator A5021135425 @default.
- W2136318351 date "2010-06-01" @default.
- W2136318351 modified "2023-09-23" @default.
- W2136318351 title "Pharmacokinetic-Pharmacodynamic-Model-Guided Doripenem Dosing in Critically Ill Patients" @default.
- W2136318351 cites W1501112436 @default.
- W2136318351 cites W1972435607 @default.
- W2136318351 cites W1972497850 @default.
- W2136318351 cites W1972911755 @default.
- W2136318351 cites W1981568603 @default.
- W2136318351 cites W2011858141 @default.
- W2136318351 cites W2024275624 @default.
- W2136318351 cites W2050731330 @default.
- W2136318351 cites W2058974499 @default.
- W2136318351 cites W2071583935 @default.
- W2136318351 cites W2076927597 @default.
- W2136318351 cites W2078645381 @default.
- W2136318351 cites W2079691262 @default.
- W2136318351 cites W2097605073 @default.
- W2136318351 cites W2101273146 @default.
- W2136318351 cites W2103780797 @default.
- W2136318351 cites W2104346641 @default.
- W2136318351 cites W2113717321 @default.
- W2136318351 cites W2114136311 @default.
- W2136318351 cites W2119658374 @default.
- W2136318351 cites W2131443556 @default.
- W2136318351 cites W2134050420 @default.
- W2136318351 cites W2143024482 @default.
- W2136318351 cites W2143150107 @default.
- W2136318351 cites W2148942014 @default.
- W2136318351 cites W2157687806 @default.
- W2136318351 cites W2160331061 @default.
- W2136318351 cites W2161209134 @default.
- W2136318351 cites W2165099632 @default.
- W2136318351 cites W2887639600 @default.
- W2136318351 cites W36177659 @default.
- W2136318351 doi "https://doi.org/10.1128/aac.01843-09" @default.
- W2136318351 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2876367" @default.
- W2136318351 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20385857" @default.
- W2136318351 hasPublicationYear "2010" @default.
- W2136318351 type Work @default.
- W2136318351 sameAs 2136318351 @default.
- W2136318351 citedByCount "51" @default.
- W2136318351 countsByYear W21363183512012 @default.
- W2136318351 countsByYear W21363183512013 @default.
- W2136318351 countsByYear W21363183512014 @default.
- W2136318351 countsByYear W21363183512015 @default.
- W2136318351 countsByYear W21363183512016 @default.
- W2136318351 countsByYear W21363183512017 @default.
- W2136318351 countsByYear W21363183512018 @default.
- W2136318351 countsByYear W21363183512020 @default.
- W2136318351 countsByYear W21363183512022 @default.
- W2136318351 countsByYear W21363183512023 @default.
- W2136318351 crossrefType "journal-article" @default.
- W2136318351 hasAuthorship W2136318351A5006715126 @default.
- W2136318351 hasAuthorship W2136318351A5021135425 @default.
- W2136318351 hasAuthorship W2136318351A5023581417 @default.
- W2136318351 hasAuthorship W2136318351A5075045252 @default.
- W2136318351 hasBestOaLocation W21363183511 @default.
- W2136318351 hasConcept C111113717 @default.
- W2136318351 hasConcept C112705442 @default.
- W2136318351 hasConcept C126322002 @default.
- W2136318351 hasConcept C159641895 @default.
- W2136318351 hasConcept C2777288759 @default.
- W2136318351 hasConcept C2777821550 @default.
- W2136318351 hasConcept C2778368673 @default.
- W2136318351 hasConcept C2779375183 @default.
- W2136318351 hasConcept C2780306776 @default.
- W2136318351 hasConcept C2908647359 @default.
- W2136318351 hasConcept C3019249092 @default.
- W2136318351 hasConcept C501593827 @default.
- W2136318351 hasConcept C71924100 @default.
- W2136318351 hasConcept C86803240 @default.
- W2136318351 hasConcept C89423630 @default.
- W2136318351 hasConcept C94665300 @default.
- W2136318351 hasConcept C98274493 @default.
- W2136318351 hasConcept C99454951 @default.
- W2136318351 hasConceptScore W2136318351C111113717 @default.
- W2136318351 hasConceptScore W2136318351C112705442 @default.
- W2136318351 hasConceptScore W2136318351C126322002 @default.
- W2136318351 hasConceptScore W2136318351C159641895 @default.
- W2136318351 hasConceptScore W2136318351C2777288759 @default.
- W2136318351 hasConceptScore W2136318351C2777821550 @default.
- W2136318351 hasConceptScore W2136318351C2778368673 @default.
- W2136318351 hasConceptScore W2136318351C2779375183 @default.
- W2136318351 hasConceptScore W2136318351C2780306776 @default.
- W2136318351 hasConceptScore W2136318351C2908647359 @default.
- W2136318351 hasConceptScore W2136318351C3019249092 @default.
- W2136318351 hasConceptScore W2136318351C501593827 @default.
- W2136318351 hasConceptScore W2136318351C71924100 @default.
- W2136318351 hasConceptScore W2136318351C86803240 @default.
- W2136318351 hasConceptScore W2136318351C89423630 @default.
- W2136318351 hasConceptScore W2136318351C94665300 @default.
- W2136318351 hasConceptScore W2136318351C98274493 @default.